Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ) (CAT#: HPAB-0440-YJ)
This product is a recombinant Mouse antibody that recognizes CD19 scFv (FMC63). The antibody was expressed in mammalian cells with chemically defined culture media and was purified by affinity chromatography.
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
Figure 1 Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ) in SDS-PAGE
Lane 1: Non-reduced mAb
Lane 2: Reduced mAb
Figure 2 Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ) in HPLC
The purity of HPAB-0440-YJ was greater than 95% as determined by SEC-HPLC.
Figure 3 Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ, Lot#CB0822JF05) in SDS-PAGE
SDS-PAGE analysis of HPAB-0440-YJ in non-reduced (Lane 1) and reduced (Lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result, different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively.
The purity of HPAB-0440-YJ was greater than 95% as determined by SDS-PAGE.
Figure 4 Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ, Lot#CB0822JF05) in HPLC
The purity of HPAB-0440-YJ was greater than 95% as determined by SEC-HPLC.
Figure 5 Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ, Lot#CB0822JF05) in ELISA
ELISA analysis of HPAB-0440-YJ was performed by coating with FMC63 antibody.
HPAB-0440-YJ is labeled with biotin and detected by HRP-SA
Figure 6 Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ)-Fc silenced in SDS-PAGE
SDS-PAGE analysis of HPAB-0440-YJ, Fc silenced, in β-mercaptoethanol-reduced (Lane 2) and non-reduced (Lane 1) conditions.
Figure 7 Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ)-Fc silenced in SEC-HPLC
The purity of HPAB-0440-YJ, Fc silenced, was greater than 98% as determined by SEC-HPLC.
Figure 8 Anti-CD19 scFv (FMC63) Recombinant Antibody (HPAB-0440-YJ)-Fc silenced in WB
Western blot analysis of HPAB-0440-YJ, Fc silenced, was performed by loading HPAB-0440-YJ-FcS as antigen. TAB-1611CL-F(E) as antibody.
Specifications
- Immunogen
- L Cells expressing CD19scFvmCD8a
- Host Species
- Mouse
- Type
- Mouse IgG
- Specificity
- Mouse antibody scFv (FMC63)
- Species Reactivity
- Mouse
- Applications
- ELISA, FC, WB, Inhib, IHC
- Related Disease
- Cancer
Product Property
- Purity
- >95% as determined by SDS-PAGE
- Concentration
- Please refer to the vial label for the specific concentration.
- Buffer
- PBS
- Preservative
- No preservatives
- Storage
- Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- CD19 scFv; FMC63
Related Resources
Gravina, Alessia, et al. "Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression." Nature biotechnology 41.5 (2023): 717-727. https://doi.org/s41587-022-01540-7
The study investigates the protection of cell therapeutics from antibody-mediated killing through the overexpression of CD64. This approach enhances the survival and efficacy of allogeneic cell therapeutics used in cancer therapy and regenerative medicine. The research demonstrates that engineered cells overexpressing CD64 can effectively evade antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), which are primary mechanisms of antibody-mediated rejection.
At Creative Biolabs, we provided several essential reagents for this research. These included the humanized anti-MICA IgG1 antibody (Cat#: TAB-0799CL), the humanized anti-CD52 IgG1 antibody (Cat#: FAMAB-0089WJ), the humanized anti-CD52 IgG1 antibody (Cat#: FAMAB-0014JF), and the hypusine antibody (Cat#: HPAB-0440-YJ). Our products were crucial for the experiments involving antibody-mediated killing assays, enabling the detailed examination of how engineered cells can evade immune detection and destruction. This study highlights the potential of CD64 overexpression to enhance the viability of cell-based therapies, underscoring our commitment to supporting advanced research and innovative therapeutic solutions.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "CD19 scFv (FMC63)"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0440-YJ-S(P) | Mouse Anti-CD19 scFv (FMC63) Recombinant Antibody; scFv Fragment (HPAB-0440-YJ-S(P)) | ELISA, FC, WB, Inhib, IHC | Mouse scFv |
Customer Reviews and Q&As
Excellent for Targeting CD19
High Specificity and Sensitivity
Reliable in Multiple Assays
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# HPAB-0440-YJ, RRID: AB_3111397)
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, WB
Application: IP, IF, FuncS, FC, Neut, ELISA, IHC
Application: ELISA, FC, IP, FuncS, IF, Neut, WB
Application: WB, ELISA, FuncS
Application: IHC, ELISA, FC, WB, ADCC, FuncS
Application: Neut, Inhib, FC, ELISA
Application: WB, ELISA, Neut, FuncS
Application: ELISA, WB, Microarray, Block
Application: ELISA, Neut, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.